Evaluation of Indication-Based Pricing for Oncology Biologic

May 24, 2016 BACK TO RESOURCES

 OBJECTIVE:

Evaluate potential strategies to implement Indication Based Pricing (IBP) and understand impact to ASP and other reimbursement/payment metrics.

APPROACH:

  • Identification of key operational issues related to implementing IBP
  • Quantitative modeling of impact of discounting to product ASP

OUTPUT:

  • Potential design of IBP-like test case in private payer market
  • Plan for approaching CMS regarding IBP demonstration
  • Quantified revenue impact of IBP under various scenarios

AUDIENCE:

Senior executives

USE BY CLIENT:

The client is still determining next steps with regards to pursuing two possible avenues regarding IBP.